Literature DB >> 16580091

Peripheral ghrelin participates in the glucostatic signaling mediated by the ventromedial and lateral hypothalamus neurons.

Andrew Solomon1, Brant A De Fanti, J Alfredo Martínez.   

Abstract

Employing immunohistochemistry techniques, we examined the c-fos expression in different hypothalamic areas, when plasma glucose levels were modified by the administration of insulin and 2-deoxyglucose (2-DG) respectively. Subsequently, the hypoglycemia produced by an injection of insulin significantly increased feeding concomitant to higher c-fos expression in the arcuate nucleus (ARC), paraventricular nucleus (PVN), dorsomedial hypothalamus (DMH) and lateral hypothalamus (LH), while no statistical changes in the ventromedial hypothalamus (VMH) were found. Also, the glucopenia induced by 2-DG administration produced similar stimulatory effects on appetite and the neuronal activity affecting all the hypothalamic areas studied, including the VMH. The peripheral blockade of the orexigenic hormone ghrelin with a specific antibody (AGA) significantly decreased food intake as induced from acute hypoglycemia and glucopenia. Curiously, the conjoint AGA and insulin or 2-DG administration produced a differential effect on the hypothalamic neurons analyzed, by increasing the number of c-fos positive neurons in the ARC, PVN and DMH, but not in the VMH and LH. This outcome suggests an interactive effect of the glucostatic pathways involving these two areas with the ghrelin signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580091     DOI: 10.1016/j.peptides.2006.02.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Glucagon-like peptide 1 (GLP-1) can reverse AMP-activated protein kinase (AMPK) and S6 kinase (P70S6K) activities induced by fluctuations in glucose levels in hypothalamic areas involved in feeding behaviour.

Authors:  Verónica Hurtado-Carneiro; Carmen Sanz; Isabel Roncero; Patricia Vazquez; Enrique Blazquez; Elvira Alvarez
Journal:  Mol Neurobiol       Date:  2012-02-05       Impact factor: 5.590

Review 2.  Role of ghrelin in the pathophysiology of eating disorders: implications for pharmacotherapy.

Authors:  Sebastian Cardona Cano; Myrte Merkestein; Karolina P Skibicka; Suzanne L Dickson; Roger A H Adan
Journal:  CNS Drugs       Date:  2012-04-01       Impact factor: 5.749

3.  Glucose-mediated control of ghrelin release from primary cultures of gastric mucosal cells.

Authors:  Ichiro Sakata; Won-Mee Park; Angela K Walker; Paul K Piper; Jen-Chieh Chuang; Sherri Osborne-Lawrence; Jeffrey M Zigman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-13       Impact factor: 4.310

4.  PAS kinase as a nutrient sensor in neuroblastoma and hypothalamic cells required for the normal expression and activity of other cellular nutrient and energy sensors.

Authors:  Verónica Hurtado-Carneiro; Isabel Roncero; Enrique Blazquez; Elvira Alvarez; Carmen Sanz
Journal:  Mol Neurobiol       Date:  2013-06-14       Impact factor: 5.590

5.  Rapid-onset hypoglycemia suppresses Fos expression in discrete parts of the ventromedial nucleus of the hypothalamus.

Authors:  Nicholas N Foster; Sana Azam; Alan G Watts
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-03-30       Impact factor: 3.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.